Defenses & Counterclaims II Class Notes: March 25, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.

Slides:



Advertisements
Similar presentations
Prosecution Lunch Patent January Extended Missing Parts Pilot Program Requirements –A non-provisional meeting filing-date standards and claiming.
Advertisements

Joint Meeting of PIPLA and NJIPLA February 7, 2012 Kenneth N. Nigon RatnerPrestia 1.
Slide 0 Refusals To License IP Jonathan I. Gleklen Partner Arnold & Porter The opinions expressed are those of the author and do not necessarily represent.
1 Rule 132 Declarations and Unexpected Results Richard E. Schafer Administrative Patent Judge Board of Patent Appeals and Interferences.
G & B Seminar 2006 Duty of Disclosure for Enforceable/Valid U.S. Patents Daniel Moon.
The America Invents Act (AIA) - Rules and Implications of First to File, Prior Art, and Non-obviousness -
September 14, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December.
© COPYRIGHT DICKSTEIN SHAPIRO LLP. ALL RIGHTS RESERVED. The Leahy-Smith America Invents Act: Changes to United States Patent Law and Practice Charles.
The Changing Law of Inequitable Conduct Rachel Zimmerman of Merchant & Gould Rebecca Thorson of Robins, Kaplan, Miller & Ciresi presented by.
AMERICA INVENTS ACT A Look Into The Future
Antitrust Counterclaims: The Basics Daniel M. Wall San Francisco
Determination of Obviousness Practice Under the Genus-Species Guidelines and In re Ochiai; In re Brouwer Sreeni Padmanabhan & James Wilson Supervisory.
Patent Controls on GM Crop Farming Janice M. Mueller Professor of Law University of Pittsburgh School of Law April 15, 2005.
Greg H. Gardella Ex Parte and Inter Partes Reexamination Tactics AIPLA 2010 Winter Institute.
Go Back, Jack, Do it Again: Reissue and Reexam Patent Law
Intellectual Property Boston College Law School February 26, 2009 Patent – Defenses.
by Eugene Li Summary of Part 3 – Chapters 8, 9, and 10
Standards Setting Organizations Groups of industry professionals Represented by Corporations Experts in the field “The public” Other interested parties.
Written Patent Discovery  Decline of notice pleading and its impact on patent litigation  Rule 26, FRCP and written patent discovery  Local Patent Rules.
Anthony Venturino MILANO 10 February 2012 SELECTED PROVISIONS OF THE LEAHY Smith AMERICA INVENTS ACT OF 2011 AIPPI - AIPLA 1 © AIPLA
January 28, AIPLA Conference January 2004 New Defensive Tools For Japanese Patent Litigation Yoshikazu Iwase Anderson.
Defenses Not Based on Prior Art  Indefiniteness  Nonenablement  Written description  Inventorship  Laches  Equitable estoppel  Statute of limitations.
1 EXAMINER’S REASONS FOR ALLOWANCE Samson Helfgott Director of Patents KMZ Rosenman New York, N.Y. January, To Respond, or not to Respond?
© 2011 Baker & Hostetler LLP BRAVE NEW WORLD OF PATENTS plus Case Law Updates & IP Trends ASQ Quality Peter J. Gluck, authored by.
Impact of US AIA: What Really Changed? 1 © AIPLA 2015.
The Patent Document II Class Notes: January 23, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
Patent Law Presented by: Walker & Mann, LLP Walker & Mann, LLP 9421 Haven Ave., Suite 200 Rancho Cucamonga, Ca Office.
Ethical Issues for Patent Prosecution Attorneys and Patent Litigators Related to the Duty of Candor and Inequitable Conduct April 22, 2008 Presentation.
Patents III Novelty and Loss of Rights Class 13 Notes Law 507 | Intellectual Property | Spring 2004 Professor Wagner.
Obviousness II Class Notes: February 11, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
July 18, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December 10,
Prosecution Lunch Patents January Reminder: USPTO Fee Changes- Jan. 1, 2014 Issue Fee Decrease- delay paying if you can –Issue Fee: from $1,780.
CIVILITY AND BEST PRACTICES IN PROSECUTION INTERACTIONS Esther Kepplinger Wilson Sonsini Goodrich & Rosati BCP September 5, 2012.
Patents V Claim Construction Class Notes: March 7, 2003 Law 507 | Intellectual Property | Spring 2003 Professor Wagner.
Patents VI Infringement & the Doctrine of Equivalents Class 16 Notes Law 507 | Intellectual Property | Spring 2004 Professor Wagner.
1 Inequitable Conduct in the Prosecution of Pharmaceutical and Biotechnology Patents Stephen D. Harper, Ph.D RatnerPrestia April 1, 2011.
Indirect Infringement Defenses & Counterclaims Class Notes: March 20, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
Infringement & the Doctrine of Equivalents III Class Notes: March 6, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
Side 1 Andrew Chin AndrewChin.com A Quick Survey of the America Invents Act Patent Law October 12, 2011.
Revisions to Japanese Patent Law Before the law was revised, a Divisional Applications could not be filed after a Notice of Allowance 2.
© 2013 Kilpatrick Townsend December 4, 2013 Best Practices – Ethics Issues in the Patent Area Presented by Thomas Franklin, Partner Kristopher Reed, Partner.
© COPYRIGHT DICKSTEIN SHAPIRO LLP. ALL RIGHTS RESERVED. Post Grant Proceedings Before the USPTO and Litigation Strategies Under the AIA Panelists:David.
QualityDefinition.PPACMeeting AdlerDraft 1 1 Improving the Quality of Patents Marc Adler PPAC meeting June 18, 2009.
The Subject Matter of Patents II Class Notes: April 8, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
Patents IV Nonobviousness
Patents I Introduction to Patent Law Class Notes: February 19, 2003 Law 507 | Intellectual Property | Spring 2003 Professor Wagner.
Claims Proposed Rulemaking Main Purposes É Applicant Assistance to Improve Focus of Examination n Narrow scope of initial examination so the examiner is.
Derivation Proceedings Gene Quinn Patent Attorney IPWatchdog.com March 27 th, 2012.
Prosecution Group Luncheon Patent October PTO News Backlog of applications continues to decrease –623,000 now, decreasing about 5,000/ month –Expected.
Patent Remedies Class Notes: April 1, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
Intellectual Property Patent – Infringement. Infringement 1.Literal Infringement 2.The Doctrine of Equivalents 35 U.S.C. § 271 –“(a) Except as otherwise.
Defenses & Counterclaims III Class Notes: March 27, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner.
Patents II Disclosure Requirements Class 12 Notes Law 507 | Intellectual Property | Spring 2004 Professor Wagner.
Patents and the Patenting Process Patents and the Inventor’s role in the Patenting Process.
PTAB Litigation 2016 Part 6 – Patent Owner Response 1.
Recent Developments in Obtaining and Enforcing Intellectual Property Rights in Nanocomposites Michael P. Dilworth February 28, 2012.
1/30 PRESENTED BY BRAHMABHATT BANSARI K. M. PHARM PART DEPARTMENT OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLGY L. M. COLLEGE OF PHARMACY.
Comments on Petherbridge, et al., Unenforceability Discussant: Brian Love 7 th Annual Conference on Empirical Legal Studies November 9, 2012.
Trademarks III Infringement of Trademarks
© 2006 Brett J. Trout Patent Reform Act of 2005 © 2006 Brett J. Trout
Pre-Issuance (Third-Party) Submissions
America Invents Act: Litigation Related Provisions
Loss of Right Provisions
Patents VI Infringement & the Doctrine of Equivalents
The Novelty Requirement I
Patents IV Nonobviousness
Law 677 | Patent Law | Spring 2003
Patents II Disclosure Requirements
US Antitrust Limitations on Patent Licensing
Chapter 4: Patents and Trade Secrets in the Information Age.
Presentation transcript:

Defenses & Counterclaims II Class Notes: March 25, 2003 Law 677 | Patent Law | Spring 2003 Professor Wagner

03/25/032Law 677 | Spring 2003 Today’s Agenda 1.Inequitable Conduct 2.Patent Misuse & Antitrust 3.First Sale 4.Implied License 5.Repair versus Reconstruction

03/25/033Law 677 | Spring 2003 Inequitable Conduct Considers Behavior Before the PTO Can include misrepresentations, failure to disclose, or submission of false informationCan include misrepresentations, failure to disclose, or submission of false information Test:Test: 1.Establish that baseline levels of materiality and intent exist. (Factual analysis.) 2.Balance materiality and intent to determine inequities involved. (Discretion by Court.)

03/25/034Law 677 | Spring 2003 Inequitable Conduct: Intent Kingsdown Medical Consultants (Fed. Cir. 1988) What did Kingsdown’s patent attorney do? Why does the court emphasize that the claims-at- issue were patentable? (How does this fit in the analysis?) Why does gross negligence ≠ intent for IC? (Can’t gross negligence cause the same problems for the PTO/public that inequitable conduct is designed to address?) What is the ‘rule’ for intent? (What is the intent to be directed towards?) How do you show it?

03/25/035Law 677 | Spring 2003 Inequitable Conduct: Materiality Critikon v Becton-Dickenson (Fed. Cir. 1997) Why take the materiality standard from the PTO’s rules? oPre-1992: ‘important to a reasonable examiner’ oPost-1992: ‘establishes prima facie case of invalidity / refutes argument put forth my applicant” Why does the court find that the McDonald patent should have been disclosed? (How does one know when a prior art reference is sufficiently unrelated to not disclose?) Why should the existence of litigation concerning the patent have been disclosed during reissue? What does the court’s expansive approach to materiality suggest about incentives to search for prior art?

03/25/036Law 677 | Spring 2003 Inequitable Conduct: Hypos Halfway through the prosecution process, you find relevant prior art. In order to avoid slowing the process, you simply amend the claim to avoid the art (everyone agrees you were successful in doing so) rather than notifying the examiner. Inequitable conduct? After finding relevant prior art, you file a notice with the PTO, listing the problematic reference together with 35 other less relevant (but not irrelevant) documents. Inequitable conduct? You claim to have submitted the quantity or art to impress the examiner with the scope of your search. Any change? The inventor of the patent application you are prosecuting tells you that she does not know of any relevant prior art; accordingly, you do not notify the PTO of any. After the patent has issued, it becomes clear that the inventor did know of relevant prior art. Inequitable conduct?

03/25/037Law 677 | Spring 2003 Patent Misuse Misuse: impermissibly broadening the physical or temporal scope of the patent Mallinckrodt v Medipart (Fed. Cir. 1992) Why do you think Mallinckrodt marks its device for ‘one use only’? (What are the social benefits?) What is the argument that the restriction on reuse is a form of patent misuse? What, specifically, are the things a patentee cannot do under the misuse doctrine? oTie-in oPrice-fixing oOther? How does the court describe the analysis/rule?

03/25/038Law 677 | Spring 2003 Patent-Antitrust Key case: In re ISO II (Fed. Cir. 2001) Xerox refuses to sell patented parts to ISOs, with the goal of expanding into the service market Why does the Federal Circuit decline to find an antitrust violation? (Do you agree?) Consider the following antitrust violations: oIllegal tying oFraud at the PTO (Walker-Process Fraud) oSham Litigation oDoes this exhaust the list of problematic circumstances? Do you agree with the view that patentees may refuse to deal, but may not condition sales where anticompetitive concerns exist?

03/25/039Law 677 | Spring 2003 First Sale Limitations on Patent Rights 1.First Sale Doctrine 2.The Doctrine of Implied License 3.Repair versus Reconstruction First Sale Doctrine: sale of a patented product implies … Purchasers can use the product Purchasers can re-sell the product Note: can be overridden by contract terms What is the theory supporting this doctrine?

03/25/0310Law 677 | Spring 2003 Implied License / Repair & Reconstruction Implied license: arises from equitable estoppel Typically requires ‘inferred consent’ to use the patented invention Repair versus Reconstruction Repair: okay; reconstruction: not okay (Why?) Key issue: how to determine repair/reconstruction line

03/25/0311Law 677 | Spring 2003 Next Class Defenses & Counterclaims III Limitations on Patent Licenses First Inventor Defense Experimental Use Defense